Presentations

Peri-operative Management of High-Risk CSCC

2024
AAD Meeting
CSCC

Pearls on peri-omanagement of high-risk resectable CSCC
Mar 9, 2025
David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

2025
CME
CSCC
BCC

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Feb 3, 2025
David M. Miller

Controversies in Gene Expression Profiling

2025
SCC
GEP
ODAC
ODAC Dermatology, Aesthetic & Surgical Conference “General Session”
Jan 19, 2025
David M. Miller

Immunotherapy for CSCC - What Dermatologists Should Know

2025
SCC
ODAC
ODAC Dermatology, Aesthetic & Surgical Conference “General Session”
Jan 19, 2025
David M. Miller

Collaborative Approaches to Optimize Basal Cell Carcinoma Care Within the Community

2025
CME
BCC

Management Pearls for Advanced BCC
Jan 8, 2025
David M. Miller

The Evolving Treatment Landscape for CSCC

2024
ADA Meeting
Squamous Cell Carcinoma

Reflections on the evolving treatment landscape for CSCC
Oct 24, 2024
David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

2024
CME
CSCC
BCC

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Oct 1, 2024
David M. Miller

Optimizing Melanoma Outcomes in Rural and Underserved Communities: Adapting to Evolving Treatment Paradigms

2024
Oncology Congress
Melanoma
CME

We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous melanoma
Sep 28, 2024
David M. Miller

Update in the Management of Advanced Cutaneous Squamous Cell Carcinoma

2024
CME
CSCC
Las Vegas Dermatology

This live program will explore key clinical practice insights for patients with advanced CSCC
Sep 21, 2024
David M. Miller

Update in the Management of Non-Resectable Melanoma

2024
CME
Melanoma
Las Vegas Dermatology

This live program will explore key clinical practice insights for patients with non-resectable melanoma
Sep 21, 2024
David M. Miller

Shifting the Approach to Nonmelanoma Skin Cancer in Dermatology

2024
CME
CSCC
BCC
Las Vegas Dermatology

This live program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Sep 20, 2024
David M. Miller

Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

2024
CME
CSCC
BCC

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Sep 19, 2024
David M. Miller

A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies

2024
CME
BCC

This program will explore key clinical practice insights for patients with advanced basal cell carcinoma
Sep 4, 2024
David M. Miller, Todd Schlessinger

Incorporating Multidisciplinary Care and Immunotherapy to Achieve Optimal Outcomes in Patients With Nonmelanoma Skin Cancers

2024
CME
Holovision
CSCC
BCC

This HoloVision program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Aug 9, 2024
David M. Miller

Should Ipilimumab Be the New “Standard” for Refractory MCC?

2024
Merkel Cell Carcinoma
Ipilimumab
Ipi/Nivo

We discuss the role of Ipilimumab in anti-PD1 refractory MCC
May 3, 2024
David M. Miller

Updates in Merkel Cell Carcinoma

2024
AAD Meeting
Merkel Cell Carcinoma

Pearls on the current concepts in diagnosis and management of MCC
Mar 10, 2024
David M. Miller

Peri-operative Management of CSCC

2024
AAD Meeting
CSCC

Pearls on peri-omanagement of high-risk resectable CSCC
Mar 9, 2024
David M. Miller

The Prognostic Value of the MCPyV Serum Antibody Test

2024
Merkel Cell Carcinoma

We discuss results from a dual-institution observational study
Mar 8, 2024
David M. Miller

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

2024
CME
TeleECHO

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Jan 19, 2024
David M. Miller

Melanoma Update

2024
Melanoma
ODAC
ODAC Dermatology, Aesthetic & Surgical Conference “Medical & Surgical Dermatology Topics”
Jan 14, 2024
David M. Miller

Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management

2024
MCC
ODAC
ODAC Dermatology, Aesthetic & Surgical Conference “Non-Melanoma Skin Cancer Update”
Jan 13, 2024
David M. Miller

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

2024
CME
TeleECHO

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Jan 5, 2024
David M. Miller

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer

2024
CME
TeleECHO

This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Jan 3, 2024
David M. Miller

Interdisciplinary Management of Advanced Cutaneous Malignancy

2023
CME
Las Vegas Dermatology
Melanoma

Management Pearls for the Peri-Operative Management of Melanoma
Nov 3, 2023

Putting the Patient First. The Value of Personalized Medicine for Nonmelanoma Skin Cancers

2023
CME
CSCC
BCC
ESMO

Management Pearls for Advanced NMSC
Oct 22, 2023
No matching items